Growth & profitability
- Revenue has grown 8.3% per year over the past 5 years.
Financial health
- Operating income covered interest expense -2256.4× in the latest year.
LUCD Financials Lucid Diagnostics Inc.
6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $5M | -$58M | -41.7% | -1054.8% | -$47M | — | — |
| 2024 | $4M | -$46M | -63.3% | -1059.6% | -$44M | — | $22M |
| 2023 | — | -$53M | — | — | — | — | $19M |
| 2022 | — | -$56M | — | — | -$33M | — | $22M |
| 2021 | — | -$28M | — | — | -$19M | — | $54M |
| 2020 | — | -$8M | — | — | — | $13M | — |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1M | -$14M | -29.4% | -964.5% | -$12M | — | — |
| Dec '25 | — | -$16M | — | — | — | — | — |
| Sep '25 | — | -$10M | — | — | — | — | $47M |
| Jun '25 | — | -$4M | — | — | — | — | $31M |
| Mar '25 | $828000 | -$27M | -87.3% | -1508.1% | -$13M | — | $25M |
| Dec '24 | — | -$12M | — | — | — | — | $22M |
| Sep '24 | — | -$12M | — | — | — | — | $14M |
| Jun '24 | — | -$11M | — | — | — | — | $25M |
| Mar '24 | — | -$11M | — | — | — | — | $25M |
| Dec '23 | — | -$11M | — | — | — | — | $19M |
| Sep '23 | — | -$14M | — | — | — | — | $24M |
| Jun '23 | — | -$11M | — | — | — | — | $33M |
| Mar '23 | — | -$16M | — | — | -$7M | — | $40M |
| Dec '22 | — | -$15M | — | — | -$4M | — | $22M |
| Sep '22 | — | -$14M | — | — | -$7M | — | $27M |
| Jun '22 | — | -$15M | — | — | -$15M | — | — |
| Mar '22 | — | -$12M | — | — | -$6M | — | — |
| Dec '21 | — | -$11M | — | — | -$11M | — | $54M |
| Sep '21 | — | -$7M | — | — | -$2M | $24M | — |
| Jun '21 | — | -$6M | — | — | -$2M | — | — |
Valuation over time
How the market has priced LUCD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-sales ratio has risen from 37.8× (Dec '24) to 44.4× (Jun '26).
P/S
Frequently asked questions
Is LUCD growing its revenue and profit?
Over the past 5 years, Lucid Diagnostics Inc.'s revenue has grown 8.3% per year. These are computed facts, not advice.
How much debt does LUCD have?
As of FY2025, Lucid Diagnostics Inc. reported — of total debt against — of cash; operating income covered interest expense -2256.4×.
What is LUCD's profit margin?
In FY2025, gross margin was -41.7%, operating margin -1054.8%, and net margin -1232.7%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.